Tissue-engineered vascular grafts: does cell seeding matter?

Tamar L. Mirensky, Narutoshi Hibino, Rajendra F. Sawh-Martinez, Tai Yi, Gustavo Villalona, Toshiharu Shinoka, Christopher K. Breuer

Research output: Contribution to journalArticle

Abstract

Purpose: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. Methods: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. Results: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 ± 0.155 mm) and those seeded without monocytes (0.771 ± 0.121 mm; P = .021) at 6 months. Conclusions: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success.

Original languageEnglish (US)
Pages (from-to)1299-1305
Number of pages7
JournalJournal of Pediatric Surgery
Volume45
Issue number6
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Blood Vessel Prosthesis
Monocytes
Transplants
Bone Marrow Cells
Inferior Vena Cava
Histological Techniques
Severe Combined Immunodeficiency
X-Ray Microtomography
Congenital Heart Defects
Smooth Muscle Myocytes
Aneurysm
Ultrasonography
Pathologic Constriction
Collagen
Growth
Population

Keywords

  • Cell seeding
  • Mononuclear cells
  • Tissue-engineering
  • Vascular conduit
  • Vascular graft

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Mirensky, T. L., Hibino, N., Sawh-Martinez, R. F., Yi, T., Villalona, G., Shinoka, T., & Breuer, C. K. (2010). Tissue-engineered vascular grafts: does cell seeding matter? Journal of Pediatric Surgery, 45(6), 1299-1305. https://doi.org/10.1016/j.jpedsurg.2010.02.102

Tissue-engineered vascular grafts : does cell seeding matter? / Mirensky, Tamar L.; Hibino, Narutoshi; Sawh-Martinez, Rajendra F.; Yi, Tai; Villalona, Gustavo; Shinoka, Toshiharu; Breuer, Christopher K.

In: Journal of Pediatric Surgery, Vol. 45, No. 6, 2010, p. 1299-1305.

Research output: Contribution to journalArticle

Mirensky, TL, Hibino, N, Sawh-Martinez, RF, Yi, T, Villalona, G, Shinoka, T & Breuer, CK 2010, 'Tissue-engineered vascular grafts: does cell seeding matter?', Journal of Pediatric Surgery, vol. 45, no. 6, pp. 1299-1305. https://doi.org/10.1016/j.jpedsurg.2010.02.102
Mirensky TL, Hibino N, Sawh-Martinez RF, Yi T, Villalona G, Shinoka T et al. Tissue-engineered vascular grafts: does cell seeding matter? Journal of Pediatric Surgery. 2010;45(6):1299-1305. https://doi.org/10.1016/j.jpedsurg.2010.02.102
Mirensky, Tamar L. ; Hibino, Narutoshi ; Sawh-Martinez, Rajendra F. ; Yi, Tai ; Villalona, Gustavo ; Shinoka, Toshiharu ; Breuer, Christopher K. / Tissue-engineered vascular grafts : does cell seeding matter?. In: Journal of Pediatric Surgery. 2010 ; Vol. 45, No. 6. pp. 1299-1305.
@article{31d9c4a0308141b885d2687784aa63c5,
title = "Tissue-engineered vascular grafts: does cell seeding matter?",
abstract = "Purpose: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. Methods: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. Results: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 ± 0.155 mm) and those seeded without monocytes (0.771 ± 0.121 mm; P = .021) at 6 months. Conclusions: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success.",
keywords = "Cell seeding, Mononuclear cells, Tissue-engineering, Vascular conduit, Vascular graft",
author = "Mirensky, {Tamar L.} and Narutoshi Hibino and Sawh-Martinez, {Rajendra F.} and Tai Yi and Gustavo Villalona and Toshiharu Shinoka and Breuer, {Christopher K.}",
year = "2010",
doi = "10.1016/j.jpedsurg.2010.02.102",
language = "English (US)",
volume = "45",
pages = "1299--1305",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Tissue-engineered vascular grafts

T2 - does cell seeding matter?

AU - Mirensky, Tamar L.

AU - Hibino, Narutoshi

AU - Sawh-Martinez, Rajendra F.

AU - Yi, Tai

AU - Villalona, Gustavo

AU - Shinoka, Toshiharu

AU - Breuer, Christopher K.

PY - 2010

Y1 - 2010

N2 - Purpose: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. Methods: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. Results: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 ± 0.155 mm) and those seeded without monocytes (0.771 ± 0.121 mm; P = .021) at 6 months. Conclusions: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success.

AB - Purpose: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. Methods: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. Results: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 ± 0.155 mm) and those seeded without monocytes (0.771 ± 0.121 mm; P = .021) at 6 months. Conclusions: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success.

KW - Cell seeding

KW - Mononuclear cells

KW - Tissue-engineering

KW - Vascular conduit

KW - Vascular graft

UR - http://www.scopus.com/inward/record.url?scp=77953849571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953849571&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2010.02.102

DO - 10.1016/j.jpedsurg.2010.02.102

M3 - Article

C2 - 20620335

AN - SCOPUS:77953849571

VL - 45

SP - 1299

EP - 1305

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 6

ER -